Get the Stockscreener App
21.92
0.05%
0.06
Overview
News
Price History
Option Chain
Why BCS Down?
Discussions
Forecast
Stock Split
Dividend History
Barclays Plc Adr stock is traded at $21.92, with a volume of 9.06M.
It is up +0.05% in the last 24 hours and down -18.12% over the past month.
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; Barclays UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The US consumer bank includes a co-branded credit card and unsecured lending business. The investment bank offers global markets, financing, and advisory services.
See More
Previous Close:
$21.86
Open:
$21.2
24h Volume:
9.06M
Relative Volume:
1.42
Market Cap:
$75.55B
Revenue:
$38.38B
Net Income/Loss:
$8.17B
P/E Ratio:
9.5433
EPS:
2.2969
Net Cash Flow:
$182.70B
1W Performance:
-7.76%
1M Performance:
-18.12%
6M Performance:
+7.68%
1Y Performance:
+37.20%
1-Day Range:
$20.96
$22.01
1-Week Range:
$20.96
$23.38
52-Week Range:
$12.14
$27.70
Barclays Plc Adr Stock (BCS) Company Profile
Compare BCS vs JPM, BAC, HSBC, WFC, RY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCS
Barclays Plc Adr
|
21.93 | 75.29B | 38.38B | 8.17B | 182.70B | 2.2969 |
|
JPM
Jpmorgan Chase Co
|
290.26 | 780.74B | 279.84B | 56.78B | 100.87B | 20.01 |
|
BAC
Bank Of America Corp
|
47.92 | 349.07B | 195.40B | 30.63B | 43.43B | 3.8228 |
|
HSBC
Hsbc Holdings Plc Adr
|
85.56 | 288.12B | 134.96B | 21.97B | 105.99B | 5.9917 |
|
WFC
Wells Fargo Co
|
78.77 | 248.15B | 124.49B | 21.36B | -14.49B | 6.2615 |
|
RY
Royal Bank Of Canada
|
163.80 | 228.37B | 97.86B | 15.12B | 25.04B | 10.47 |
Barclays Plc Adr Stock (BCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-04-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-08-24 | Initiated | Goldman | Buy |
| Sep-05-24 | Initiated | Kepler | Buy |
| May-09-24 | Initiated | Deutsche Bank | Buy |
| Oct-26-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-26-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-08-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| May-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-14-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-06-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-30-21 | Upgrade | Redburn | Neutral → Buy |
| Mar-16-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-12-21 | Upgrade | Goldman | Neutral → Buy |
| Nov-10-20 | Downgrade | Investec | Buy → Hold |
| Jul-10-20 | Upgrade | Investec | Hold → Buy |
| Mar-03-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-11-20 | Resumed | Credit Suisse | Neutral |
| Nov-26-19 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Sep-05-19 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Aug-21-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Apr-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-01-18 | Upgrade | Berenberg | Hold → Buy |
| Jun-19-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-16-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-29-18 | Upgrade | Investec | Hold → Buy |
| Mar-20-18 | Downgrade | Investec | Buy → Hold |
| Mar-08-18 | Upgrade | Goldman | Sell → Neutral |
| Jan-11-18 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jan-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-15-17 | Downgrade | Investec | Buy → Hold |
| Nov-20-17 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-31-17 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Oct-20-17 | Upgrade | Berenberg | Sell → Hold |
View All
Barclays Plc Adr Stock (BCS) Latest News
Barclays Stock Dips 14.1% YTD: Is It a Buy After the Recent Pullback? - Finviz
BCS Stock Today: BoE Grills Banks on MFS Collapse Risk — March 7 - Meyka
Rosen Law Firm Encourages Barclays plc Investors to Inquire About Securities Class Action InvestigationBCS - Barchart.com
Diversified Energy TR-1 - GlobeNewswire Inc.
Barclays Bank Review 2026: Pros, Cons and Key Features - Traders Union
NatWest Group plc (NWG) Hires Ruari Phillips as Head of Venture & Growth Finance - Finviz
UBS Remains a Buy on Barclays PLC (BCS) - Finviz
Barclays PLC (NYSE:BCS) Given Average Recommendation of “Buy” by Analysts - Defense World
Barclays among lenders exposed to collapsed UK mortgage firm MFSBloomberg - Investing.com
Will Realignment Efforts Enhance Barclays' Financial Strength? - The Globe and Mail
Will Barclays' Financial Stability Benefit from Realignment Initiatives? - Bitget
Palantir Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
ETF Comparator - MacroMicro
Barclays Outlook Gains Strength Amid Return Focus - Kalkine Media
Hello Group Inc. Sponsored ADR (NASDAQ:MOMO) Short Interest Update - Defense World
Perspectives On Rotations Into Value, Small-Cap, Developed And Emerging Markets - Seeking Alpha
Barclays files 2025 annual report on Form 20-F with SEC - Investing.com Nigeria
Barclays files 2025 annual report on Form 20-F with SEC By Investing.com - Investing.com South Africa
Barclays ADR earnings beat by $0.02, revenue fell short of estimates - Investing.com Nigeria
BP Plc ADR (BP-N) Stock Price and News - The Globe and Mail
Earnings call transcript: Barclays Q4 2025 EPS beats, revenue misses - Investing.com
As UK Banks Hike Mortgage Rates, These ETFs Stand to Gain - The Globe and Mail
SiTime Corporation (SITM) Receives a Hold from Barclays - The Globe and Mail
Barclays Reaffirms Their Buy Rating on Coherent Corp (COHR) - The Globe and Mail
AstraZeneca Shares to Start Trading in US After Listing Upgrade - Bloomberg
AstraZeneca Stock to Begin US Trading Following Listing Enhancement - Bitget
Barclays Appoints Chetan Vohra as Global Head of Securitized Products - Chartmill
Barclays Banking Focus within FTSE Stocks Mid-Session Context - Kalkine Media
Barclays Sticks to Its Hold Rating for Intel (INTC) - The Globe and Mail
British banks to join European rivals in hiking profit targets, sources say - Sahm
Barclays PLC (NYSE:BCS) Shows Bull Flag Formation Ahead of Potential Breakout - ChartMill
Will Lower Active Accounts Impact Synchrony's Q4 Earnings Potential? - Finviz
JPMorgan keeps Barclays top pick as it raises U.K. bank price targets By Investing.com - Investing.com South Africa
JPMorgan keeps Barclays top pick as it raises U.K. bank price targets - Investing.com
Here's What the Wall Street Thinks About Barclays PLC (BCS) - Finviz
ARM Holdings PLC ADR (ARM): New Buy Recommendation for This Technology Giant - The Globe and Mail
Barclays Research Finds Humanoid Robotics On Track to Become a $200 Billion Market by 2035 - Chartmill
Why Nvidia's New Rubin Chips Could Spell Big Gains For This Under-the-Radar AI Stock - Finviz
FTSE 100 today: Shares edge higher, GBP strengthens; Barclays hit by Trump threat - Investing.com South Africa
Barclays Plc Adr Stock (BCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):